Intech Biopharm Corporation (TPEX:6461)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.95
-0.15 (-0.88%)
May 8, 2026, 1:23 PM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Research and Development Technology and Drug Trading Business
25.85M23.65M38.90M21.11M16.68M
Research and Development Technology and Drug Trading Business Growth
9.30%-39.21%84.30%26.50%-3.19%
Total
25.85M23.65M38.90M21.11M16.68M
Total Growth
9.30%-39.21%84.30%26.50%-3.19%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Taiwan
21.85M10.61M10.34M14.30M15.25M
Taiwan Growth
105.91%2.66%-27.70%-6.23%-1.13%
China
1.12M9.32M28.23M5.81M1.13M
China Growth
-87.99%-66.98%386.07%414.44%57.90%
Hong Kong
1.75M919.00K---
Hong Kong Growth
89.99%----
Other
1.13M2.79M---
Other Growth
-59.60%----
Malaysia
--153.00K--
Costa Rica
--177.00K--
Cambodia
---999.00K306.00K
Cambodia Growth
---226.47%-
Total
25.85M23.65M38.90M21.11M16.68M
Total Growth
9.30%-39.21%84.30%26.50%-3.19%
Source: S&P Global Market Intelligence.